Delivery Order SPE2DU25D9439-SPE2DU26FEEFQ
- Not listed
- The Defense Logistics Agency issued a $1,388.44 delivery order to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler, on February 6, 2026, under the Pharmaceutical Prime Vendor Global Program Generation V (PPV-G GEN V) contract for pharmaceutical supply to federal agencies. PPV-G GEN V is a Defense Logistics Agency indefinite delivery contract supporting the supply of branded and generic prescription drugs, over-the-counter medications, biologics, vaccines,...
- The Defense Logistics Agency issued a $4,764.20 delivery order to DMS Pharmaceutical Group Inc., a woman-owned small business, on February 4, 2026, under the Pharmaceutical Prime Vendor Global Program Generation V (PPV-G GEN V) contract for pharmaceutical supply. PPV-G GEN V is a Defense Logistics Agency indefinite delivery contract supporting the supply of branded and generic prescription medications, over-the-counter drugs, biologics, vaccines, specialty pharmaceuticals, and medical...
- The Defense Logistics Agency issued a $1,737.68 delivery order to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler, on February 17, 2026, under the Pharmaceutical Prime Vendor Global Program Generation V (PPV-G GEN V) indefinite delivery contract for pharmaceutical products. PPV-G GEN V is a Defense Logistics Agency program that authorizes firm fixed-price delivery orders for branded and generic prescription drugs, over-the-counter medications, biologics, and...
- The Defense Logistics Agency issued a $1,179.38 delivery order to DMS Pharmaceutical Group Inc., a woman-owned small business, on February 2, 2026, under the Pharmaceutical Prime Vendor Global Program Generation V (PPV-G GEN V) for pharmaceutical supply to federal military healthcare facilities. The PPV-G GEN V is a Defense Logistics Agency-administered indefinite delivery contract supporting the supply of branded and generic prescription drugs, over-the-counter medications, biologics, vaccines,...
- The Defense Logistics Agency issued a $3,184.64 delivery order to DMS Pharmaceutical Group Inc., a woman-owned small business, on February 12, 2026, under the Pharmaceutical Prime Vendor Global Program Generation V (PPV-G GEN V) for pharmaceutical products to support Department of Defense medical supply needs. PPV-G GEN V is a DLA-administered indefinite delivery contract program with a $499.9 billion ceiling across multiple regional prime vendor contractors, structured to provide firm...
- The Defense Logistics Agency issued a $4,389 delivery order to DMS Pharmaceutical Group Inc., a woman-owned small business, on February 17, 2026, under the Pharmaceutical Prime Vendor Global Program Generation V (PPV-G GEN V) indefinite delivery contract for pharmaceutical products. PPV-G GEN V is a Defense Logistics Agency single-award indefinite delivery contract with a $499.999 billion ceiling supporting firm fixed-price delivery orders for branded and generic prescription drugs,...
- The Defense Logistics Agency issued a $1,139.80 delivery order to DMS Pharmaceutical Group Inc. on February 17, 2026, under the Pharmaceutical Prime Vendor Global Program Generation V (PPV-G GEN V) for pharmaceutical products and medical consumables. PPV-G GEN V is the Defense Logistics Agency's single-award indefinite delivery contract program supporting Department of Defense healthcare operations globally with firm fixed-price delivery orders for branded and generic prescription drugs,...
- The Defense Logistics Agency issued a $1,617.78 delivery order to DMS Pharmaceutical Group Inc. on February 12, 2026, under the Pharmaceutical Prime Vendor Global Program Generation V (PPV-G GEN V) for pharmaceutical products and medical consumables. PPV-G GEN V is a Defense Logistics Agency single-award indefinite delivery contract supporting recurring pharmaceutical supply needs for Department of Defense military healthcare facilities worldwide. DMS Pharmaceutical Group Inc. is a woman-owned...
- The Defense Logistics Agency issued a $3,320.62 delivery order to DMS Pharmaceutical Group Inc., a woman-owned small business, on February 10, 2026, under the Pharmaceutical Prime Vendor Global Program Generation V (PPV-G GEN V) for pharmaceutical distribution. PPV-G GEN V is a Defense Logistics Agency indefinite delivery contract supporting the supply of branded and generic prescription drugs, over-the-counter medications, biologics, vaccines, and medical consumables to Department of Defense...
- The Defense Logistics Agency issued a $2,494.80 delivery order to DMS Pharmaceutical Group Inc., a woman-owned small business, on February 4, 2026, under the Pharmaceutical Prime Vendor Global Program Generation V (PPV-G GEN V) for pharmaceutical products. PPV-G GEN V is a Defense Logistics Agency indefinite delivery contract supporting pharmaceutical supply to Department of Defense healthcare facilities worldwide. The order is firm fixed price with place of performance in Park Ridge, IL. DMS...
- SPE2DU25D9439Indefinite Delivery Contract
- SPE2DU25D9439-SPE2DU26FEEFQDelivery Order
The Defense Logistics Agency issued a $4,173.45 delivery order to DMS Pharmaceutical Group Inc. on February 18, 2026, under the Pharmaceutical Prime Vendor Global Program Generation V (PPV-G GEN V) for pharmaceutical products. PPV-G GEN V is the Defense Logistics Agency's single-award indefinite delivery contract for pharmaceutical supply to Department of Defense healthcare facilities worldwide, with a $499.999 billion ceiling and completion date of December 31, 2036. The contract authorizes firm fixed-price delivery orders for branded and generic prescription drugs, over-the-counter medications, biologics, and medical consumables. Place of performance is Park Ridge, IL. DMS Pharmaceutical Group Inc. is a woman-owned small business pharmaceutical wholesaler. Ultimate completion date for this delivery order is February 26, 2026.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $4.2k | 2/17/26 |